NovoCure Limited (NASDAQ:NVCR) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Novocure Ltd (NVCR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 2,739,704 | $81,643,179 | 5.13% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,068,863 | $31,852,117 | +28% | 0.04% |
| 3. | Palo Alto Investors William Leland Edwards | 814,191 | $24,262,892 | +38% | 3.75% |
| 4. | Millennium Management Israel Englander | 735,227 | $21,909,765 | +172% | 0.01% |
| 5. | Renaissance Technologies Jim Simons | 734,354 | $21,883,749 | -2% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $96.50 | 104 | Officer, Director | 13,276 | 2021-11-26 | Filing | |
| $103.37 | 1,000 | Officer, Director | 13,172 | 2021-11-26 | Filing | |
| $102.36 | 3,870 | Officer, Director | 12,172 | 2021-11-26 | Filing | |
| $85.01 | 4,200 | Officer | 98,786 | 2020-09-02 | Filing | |
| $6.93 | 125,000 | Director | 6,125,000 | 2017-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.92 | 268 | 166,243 | 2025-03-03 | Filing | ||
| $18.54 | 2,527 | 143,673 | 2025-03-03 | Filing | ||
| $18.54 | 2,053 | 204,005 | 2025-03-03 | Filing | ||
| $18.54 | 250 | 29,173 | 2025-03-03 | Filing | ||
| $18.31 | 311 | 166,511 | 2025-02-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,866 | $193,632 | 0.06% | |
| 2. | 84 | $1,497 | 0% |
News See All
8 Stocks on Jim Cramer's Radar
Jim Cramer, host of Mad Money, recently discussed some of the significant challenges the alcohol industry is facing.
NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
NovoCure Limited (NASDAQ:NVCR) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the NovoCure Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43.
Aggressive Stock Portfolio: 5 Stocks Picked by Analysts
In this article, we will take a look at the aggressive stock portfolio: 5 stocks picked by analysts.
NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the NovoCure Q4 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
15 Best Falling Stocks To Buy Now
In this piece, we will take a look at the 15 best falling stocks to buy now.
11 Best Undervalued UK Stocks To Buy Now
In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now.
NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript
Operator: Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
Billionaire Hedge Funds
